![Emil Kuriakose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emil Kuriakose
Chief Tech/Sci/R&D Officer at
TERNS PHARMACEUTICALS, INC.
Profile
Dr. Emil T.
Kuriakose, MD, is a Chief Medical Officer-Oncology at Terns Pharmaceuticals, Inc. Dr. Kuriakose was previously employed as a Chief Medical Officer by Calithera Biosciences, Inc. and a Medical Director by Novartis Oncology, Inc. He received his undergraduate degree from New York University and a doctorate degree from Stony Brook University School of Medicine.
Emil Kuriakose active positions
| Companies | Position | Start |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2023-04-30 |
Former positions of Emil Kuriakose
| Companies | Position | End |
|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Chief Tech/Sci/R&D Officer | 2015-12-31 |
| CALITHERA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Emil Kuriakose
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Stony Brook University School of Medicine
 Stony Brook University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
- Stock Market
- Insiders
- Emil Kuriakose
